A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas.

Trial Profile

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2012

At a glance

  • Drugs Indinavir (Primary) ; Cancer vaccine; Influenza virus vaccines; Interleukin-2
  • Indications CNS cancer; Ewing's sarcoma; Influenza virus infections; Neuroectodermal tumours; Neuroepithelial neoplasms; Rhabdomyosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Jun 2012 Primary endpoints added as reported by ClinicalTrials.gov.
    • 22 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top